These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17392615)

  • 1. PARP inhibitors and heart failure--translational medicine caught in the act.
    Booz GW
    Congest Heart Fail; 2007; 13(2):105-12. PubMed ID: 17392615
    [No Abstract]   [Full Text] [Related]  

  • 2. PARP-1 inhibition to treat cancer, ischemia, inflammation.
    Graziani G; Battaini F; Zhang J
    Pharmacol Res; 2005 Jul; 52(1):1-4. PubMed ID: 15911328
    [No Abstract]   [Full Text] [Related]  

  • 3. Poly(ADP-ribosyl)ation and stroke.
    Chiarugi A
    Pharmacol Res; 2005 Jul; 52(1):15-24. PubMed ID: 15911330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(ADP-ribosyl)ation polymerases: mechanism and new target of anticancer therapy.
    Heitz F; Harter P; Ewald-Riegler N; Papsdorf M; Kommoss S; du Bois A
    Expert Rev Anticancer Ther; 2010 Jul; 10(7):1125-36. PubMed ID: 20645701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel modulators of poly(ADP-ribose) polymerase.
    Szabo C; Pacher P; Swanson RA
    Trends Pharmacol Sci; 2006 Dec; 27(12):626-30. PubMed ID: 17055069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [PARP (poly(ADP-ribose) polymerase) family].
    Saito H; Miki Y
    Nihon Rinsho; 2012 Nov; 70 Suppl 8():71-7. PubMed ID: 23513815
    [No Abstract]   [Full Text] [Related]  

  • 7. Mediation of cell death by poly(ADP-ribose) polymerase-1.
    Koh DW; Dawson TM; Dawson VL
    Pharmacol Res; 2005 Jul; 52(1):5-14. PubMed ID: 15911329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3. Life or death decisions: the cast of poly(ADP-ribose)polymerase (PARP) as a therapeutic target for brain ischaemia.
    Pellicciari R; Camaioni E; Costantino G
    Prog Med Chem; 2004; 42():125-69. PubMed ID: 15003720
    [No Abstract]   [Full Text] [Related]  

  • 9. Poly(ADP-ribose)polymerase 1 (PARP-1) and postischemic brain damage.
    Moroni F
    Curr Opin Pharmacol; 2008 Feb; 8(1):96-103. PubMed ID: 18032109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors.
    Virág L; Szabó C
    Pharmacol Rev; 2002 Sep; 54(3):375-429. PubMed ID: 12223530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple roles for poly(ADP-ribose)polymerase-1 in neurological disease.
    Kauppinen TM
    Neurochem Int; 2007 Jun; 50(7-8):954-8. PubMed ID: 17222947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [From poly(ADP-ribose) discovery to PARP inhibitors in cancer therapy].
    Schreiber V; Illuzzi G; Héberlé E; Dantzer F
    Bull Cancer; 2015 Oct; 102(10):863-73. PubMed ID: 26384693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting poly(ADP-ribose) polymerase-1 as a promising approach for immunomodulation in multiple sclerosis?
    Cavone L; Chiarugi A
    Trends Mol Med; 2012 Feb; 18(2):92-100. PubMed ID: 22078487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(ADP-Ribose) polymerase promotes cardiac remodeling, contractile failure, and translocation of apoptosis-inducing factor in a murine experimental model of aortic banding and heart failure.
    Xiao CY; Chen M; Zsengellér Z; Li H; Kiss L; Kollai M; Szabó C
    J Pharmacol Exp Ther; 2005 Mar; 312(3):891-8. PubMed ID: 15523000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(ADP-ribosyl)ation in asthma and other lung diseases.
    Virág L
    Pharmacol Res; 2005 Jul; 52(1):83-92. PubMed ID: 15911336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
    Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
    J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemic nitric oxide and poly (ADP-ribose) polymerase-1 in cerebral ischemia: male toxicity, female protection.
    McCullough LD; Zeng Z; Blizzard KK; Debchoudhury I; Hurn PD
    J Cereb Blood Flow Metab; 2005 Apr; 25(4):502-12. PubMed ID: 15689952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase.
    Menear KA; Adcock C; Alonso FC; Blackburn K; Copsey L; Drzewiecki J; Fundo A; Le Gall A; Gomez S; Javaid H; Lence CF; Martin NM; Mydlowski C; Smith GC
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3942-5. PubMed ID: 18579376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metabolism and cellular functions of poly(ADP-ribose)].
    Miwa M; Masutani M
    Seikagaku; 2006 Nov; 78(11):1050-61. PubMed ID: 17176893
    [No Abstract]   [Full Text] [Related]  

  • 20. Nitrosative stress and pharmacological modulation of heart failure.
    Pacher P; Schulz R; Liaudet L; Szabó C
    Trends Pharmacol Sci; 2005 Jun; 26(6):302-10. PubMed ID: 15925705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.